Notice of Meeting, 24860 [E9-12068]

Download as PDF 24860 Federal Register / Vol. 74, No. 99 / Tuesday, May 26, 2009 / Notices Dated: May 18, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. E9–12119 Filed 5–22–09; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announce the following teleconference meetings: Times and Dates: 12:30 p.m.–12:45 p.m., June 22, 2009 (Open). 12:45 p.m.–7 p.m., June 22, 2009 (Closed). 9 a.m.–9:15 a.m., June 23, 2009 (Open). 9:15 a.m.–5 p.m., June 23, 2009 (Closed). 9 a.m.–9:15 a.m., June 24, 2009 (Open). 9:15 a.m.–5 p.m., June 24, 2009 (Closed). 9 a.m.–9:15 a.m., June 25, 2009 (Open). 9:15 a.m.–5 p.m., June 25, 2009 (Closed). Place: Teleconference, Toll Free: 877–468– 4185, Participant Pass Code: 3772769. Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control. Matters To Be Discussed: The meetings will include the review, discussion, and evaluation of applications submitted in response to Fiscal Year 2009 Requests for Applications related to the following individual research announcement: RFA– EH–09–001 Climate Change: Environmental Impact on Human Health (U01). Agenda items are subject to change as priorities dictate. CONTACT PERSON FOR MORE INFORMATION: Rick Waxweiler, Ph.D., Director, Extramural Research Program Office, National Center for Injury Prevention & Control and Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, N.E., M/S F–62, Atlanta, Georgia 30341, Telephone 770–488-4850. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices Jkt 217001 Committee Management Officer, Office of Extramural Research, Education and Priority Populations, AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, Telephone (301) 427–1554. Agenda items for this meeting are subject to change as priorities dictate. Dated: May 15, 2009. Carolyn M. Clancy, Director. [FR Doc. E9–12068 Filed 5–22–09; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Center for Injury Prevention and Control Initial Review Group, (NCIPC IRG) 20:08 May 22, 2009 Dated: May 18, 2009. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E9–12120 Filed 5–22–09; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention VerDate Nov<24>2008 pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Meeting In accordance with section 10(d) of the Federal Advisory Committee Act (5 U.S.C., Appendix 2), announcement is made of a Health Care Policy and Research Special Emphasis Panel (SEP) meeting. A Special Emphasis Panel is a group of experts in fields related to health care research who are invited by the Agency for Healthcare Research and Quality (AHRQ), and agree to be available, to conduct on an as needed basis, scientific reviews of applications for AHRQ support. Individual members of the Panel do not attend regularlyscheduled meetings and do not serve for fixed terms or a long period of time. Rather, they are asked to participate in particular review meetings which require their type of expertise. Substantial segments of the upcoming SEP meeting listed below will be closed to the public in accordance with the Federal Advisory Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 552b(c)(6). Grant applications for the Accelerating Development of Methods for the Study of Complex Patients (R21) applications are to be reviewed and discussed at this meeting. These discussions are likely to reveal personal information concerning individuals associated with the applications. This information is exempt from mandatory disclosure under the above-cited statutes. SEP Meeting on: Accelerating Development of Methods for the Study of Complex Patients (R21). Date: June 23, 2009 (Open on June 23 from 1 p.m. to 1:15 p.m. and closed for the remainder of the meeting). Place: Agency for Healthcare Research and Quality, John Eisenberg Building, Conference Center, Rockville, Maryland 20850. Contact Person: Anyone wishing to obtain a roster of members, agenda or minutes of the nonconfidential portions of this meeting should contact Mrs. Bonnie Campbell, PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Pediatric Functional Neuroimaging Research Network. Date: June 26, 2009. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate contract proposals Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Sathasiva B. Kandasamy, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892–9304, (301) 435–6680, skandasa@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) E:\FR\FM\26MYN1.SGM 26MYN1

Agencies

[Federal Register Volume 74, Number 99 (Tuesday, May 26, 2009)]
[Notices]
[Page 24860]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-12068]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meeting

    In accordance with section 10(d) of the Federal Advisory Committee 
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care 
Policy and Research Special Emphasis Panel (SEP) meeting.
    A Special Emphasis Panel is a group of experts in fields related to 
health care research who are invited by the Agency for Healthcare 
Research and Quality (AHRQ), and agree to be available, to conduct on 
an as needed basis, scientific reviews of applications for AHRQ 
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of 
time. Rather, they are asked to participate in particular review 
meetings which require their type of expertise.
    Substantial segments of the upcoming SEP meeting listed below will 
be closed to the public in accordance with the Federal Advisory 
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C. 
552b(c)(6). Grant applications for the Accelerating Development of 
Methods for the Study of Complex Patients (R21) applications are to be 
reviewed and discussed at this meeting. These discussions are likely to 
reveal personal information concerning individuals associated with the 
applications. This information is exempt from mandatory disclosure 
under the above-cited statutes.

    SEP Meeting on: Accelerating Development of Methods for the 
Study of Complex Patients (R21).
    Date: June 23, 2009 (Open on June 23 from 1 p.m. to 1:15 p.m. 
and closed for the remainder of the meeting).
    Place: Agency for Healthcare Research and Quality, John 
Eisenberg Building, Conference Center, Rockville, Maryland 20850.
    Contact Person: Anyone wishing to obtain a roster of members, 
agenda or minutes of the nonconfidential portions of this meeting 
should contact Mrs. Bonnie Campbell, Committee Management Officer, 
Office of Extramural Research, Education and Priority Populations, 
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850, 
Telephone (301) 427-1554.
    Agenda items for this meeting are subject to change as 
priorities dictate.

    Dated: May 15, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9-12068 Filed 5-22-09; 8:45 am]
BILLING CODE 4160-90-M